Table 6

Final regression model variables for determinants of annual purchase of complementary or alternative medicines for osteoarthritis

β coefficientOdds ratio95% CISignificance
CI, confidence interval; MOS SF-36, medical outcomes study SF-36 health survey; WOMAC, Western Ontario and McMaster Universities osteoarthritis index.
Sex (female)0.7142.041.17 to 3.550.011
Did not purchase conventional analgesics0.8822.41.05 to 5.540.037
MOS SF-36 bodily pain0.0281.031.01 to 1.050.006
WOMAC function0.0331.031.00 to 1.070.051*